Headline
The latest stories from AHA Today.
The Food and Drug Administration yesterday authorized the Novavax COVID-19 vaccine for emergency use in adults, as recommended last month by its vaccine advisory committee.
The Centers for Medicare & Medicaid Services’ new Hospital Overall Star Ratings methodology preservessome year-to-year stability, but some ratings remain volatile.
Marie Cleary-Fishman, speaks with Holly Geyer, M.D., about the roots of the opioid epidemic and the state and federal requirements — and institutional protocols — for developing solutions.
Multiple states have reported parechovirus (PeV) cases in newborns and young infants since May, the Centers for Disease Control and Prevention alerted clinicians and public health departments yesterday.
The White House today held a summit highlighting American Rescue Plan Act investments in state and local workforce programs.
During the AHA Leadership Summit July 17-19 in San Diego, Cleveland-based University Hospitals will receive the 2022 AHA Quest for Quality Prize for its data-driven quality and safety improvements and innovative strategies to share these improvements and deliver equitable care
After declining in recent years, antimicrobial-resistant infections starting during hospitalization grew 15% from 2019 to 2020, the Centers for Disease Control and Prevention reported today, based on limited data for 2020.
The AHA and eight other national hospital organizations today urged Congress to quickly extend the American Rescue Plan Act’s enhanced premium tax credits for health coverage purchased through the Health Insurance Marketplace, which are set to expire this year.
The Department of Health and Human Services today released guidance and a letter to providers regarding HHS enforcement of the Emergency Medical Treatment and Labor Act in light of the Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization.
The departments of Health and Human Services and Defense have secured 3.2 million doses of the Novavax COVID-19 vaccine to give to states, federal pharmacy partners and federally qualified health centers.